Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia

International Journal of Antimicrobial Agents

Volumn 43, Issue 2, 2014, Pages 179-183

  Jung, Younghee ^a   Song, Kyoung Ho ^a,b   Cho, Jeong Eun ^a   Kim, Hyung Sook ^a   Kim, Nak Hyun ^b   Kim, Taek Soo ^a   Choe, Pyoeng Gyun ^b   Chung, Jae Yong ^a   Park, Wan Beom ^b   Bang, Ji Hwan ^b   Kim, Eu Suk ^a,b   Park, Kyoung Un ^a   Park, Sang Won ^b   Kim, Hong Bin ^a,b   Kim, Nam Joong ^b   Oh, Myoung Don ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Area under the concentration time curve; Bacteraemia; Methicillin resistant Staphylococcus aureus; Minimum inhibitory concentration; Vancomycin

Indexed keywords

AREA UNDER THE CONCENTRATION-TIME CURVE; BACTERAEMIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; VANCOMYCIN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTEREMIA; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMA; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84893702242     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.10.017     Document Type: Article

References (15)

1. A.J. Larsson, K.J. Walker, J.K. Raddatz, and J.C. Rotschafer The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions J Antimicrob Chemother 38 1996 589 597
2. B.H. Ackerman, A.M. Vannier, and E.B. Eudy Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response Antimicrob Agents Chemother 36 1992 1766 1769
3. P.A. Moise-Broder, A. Forrest, M.C. Birmingham, and J.J. Schentag Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections Clin Pharmacokinet 43 2004 925 942
4. R. Kullar, S.L. Davis, D.P. Levine, and M.J. Rybak Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets Clin Infect Dis 52 2011 975 981
5. 24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization Antimicrob Agents Chemother 56 2012 634 638
6. M.N. Jeffres, W. Isakow, J.A. Doherty, P.S. McKinnon, D.J. Ritchie, and S.T. Micek et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices Chest 130 2006 947 955
7. N.E. Holmes, J.D. Turnidge, W.J. Munckhof, J.O. Robinson, T.M. Korman, and M.V. O'Sullivan et al. Vancomycin AUC/MIC and 30-day mortality in patients with Staphylococcus aureus bacteremia Antimicrob Agents Chemother 57 2013 1654 1663
8. S. Zelenitsky, E. Rubinstein, R. Ariano, H. Iacovides, P. Dodek, and Y. Mirzanejad et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock Int J Antimicrob Agents 41 2013 255 260
9. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard 9th ed. 2009 CLSI Wayne, PA [Document M07-A9]
10. S.J. van Hal, T.P. Lodise, and D.L. Paterson The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis Clin Infect Dis 54 2012 755 771
11. H. Honda, C.D. Doern, W. Michael-Dunne Jr., and D.K. Warren The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia BMC Infect Dis 11 2011 335
12. L. Rojas, E. Bunsow, P. Muñoz, E. Cercenado, M. Rodríguez-Créixems, and E. Bouza Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients J Antimicrob Chemother 67 2012 1760 1768
13. Y.C. Yeh, K.M. Yeh, T.Y. Lin, S.K. Chiu, Y.S. Yang, and Y.C. Wang et al. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia J Microbiol Immunol Infect 45 2012 214 220
14. N.E. Holmes, J.D. Turnidge, W.J. Munckhof, J.O. Robinson, T.M. Korman, and M.V. O'Sullivan et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations J Infect Dis 204 2013 340 347
15. J.M. Aguado, R. San-Juan, A. Lalueza, F. Sanz, J. Rodríguez-Otero, and C. Gómez-Gonzalez et al. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia Emerg Infect Dis 17 2011 1099 1102